Hafrun Fridriksdottir
2018
In 2018, Hafrun Fridriksdottir earned a total compensation of $6M as Executive Vice President, Global Research and Development at Teva Pharmaceutical Industries, a 61% increase compared to previous year.
Compensation breakdown
| Bonus | $650,000 |
|---|---|
| Non-Equity Incentive Plan | $1,296,144 |
| Option Awards | $900,003 |
| Salary | $720,000 |
| Stock Awards | $2,321,392 |
| Other | $87,492 |
| Total | $5,975,031 |
Fridriksdottir received $2.3M in stock awards, accounting for 39% of the total pay in 2018.
Fridriksdottir also received $650K in bonus, $1.3M in non-equity incentive plan, $900K in option awards, $720K in salary and $87.5K in other compensation.
Rankings
In 2018, Hafrun Fridriksdottir's compensation ranked 1,580th out of 14,244 executives tracked by ExecPay. In other words, Fridriksdottir earned more than 88.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,580 out of 14,244 | 89th |
Division Manufacturing | 555 out of 5,758 | 90th |
Major group Chemicals And Allied Products | 174 out of 2,119 | 92nd |
Industry group Drugs | 137 out of 1,808 | 92nd |
Industry Pharmaceutical Preparations | 100 out of 1,382 | 93rd |
Source: SEC filing on April 16, 2019.
Fridriksdottir's colleagues
We found four more compensation records of executives who worked with Hafrun Fridriksdottir at Teva Pharmaceutical Industries in 2018.
2018
Kåre Schultz
Teva Pharmaceutical Industries
Chief Executive Officer
2018
Carlo de Notaristefani
Teva Pharmaceutical Industries
Executive Vice President, Global Operations
2018
Mark Sabag
Teva Pharmaceutical Industries
Executive Vice President, Global Human Resources
2018
Michael McClellan
Teva Pharmaceutical Industries